Table 2. Summary of hematological data in female rats inhaling diethylbenzene for 90 days (n = 10)

Parameters	Groups
	Control	Low (40 ppm)	Middle (80 ppm)	High (160 ppm)
WBC (× 103/μL)	2.74 ± 0.9464	2.643 ± 0.4128	3.086 ± 0.8166	3.1 ± 0.651
RBC (× 106/μL)	7.482 ± 0.3503	7.522 ± 0.2402	7.749 ± 0.4451	7.568 ± 0.2164
HGB (g/dL)	13.48 ± 0.503	13.51 ± 0.476	13.95 ± 0.624	13.59 ± 0.506
HCT (%)	40.07 ± 1.606	39.84 ± 0.999	41.64 ± 1.788	40.4 ± 1.642
MCV (fL)	53.57 ± 1.277	53 ± 1.031	53.78 ± 1.694	53.38 ± 0.95
MCH (pg)	18.00 ± 0.492	17.97 ± 0.56	18.02 ± 0.600	17.96 ± 0.309
MCHC (g/dL)	33.64 ± 0.369	33.89 ± 0.611	33.51 ± 0.412	33.63 ± 0.35
PLT (× 103/μL)	935.2 ± 99.77	1,037.2 ± 99.15	1,003.7 ± 218.25	986.6 ± 60.91
NEU% (%)	20.33 ± 5.572	18.74 ± 5.05	20.68 ± 8.960	16.14 ± 4.222
LYM% (%)	73.66 ± 6.715	75.02 ± 5.939	73.04 ± 9.171	78 ± 5.057
MON% (%)	2.79 ± 0.867	3.00 ± 0.745	2.98 ± 0.716	2.73 ± 1.456
EOS% (%)	2.03 ± 0.533	2.07 ± 0.512	1.95 ± 0.762	1.69 ± 0.925
BAS% (%)	0.15 ± 0.085	0.14 ± 0.073	0.12 ± 0.042	0.12 ± 0.083
NEUA (× 103/μL)	0.554 ± 0.237	0.482 ± 0.1049	0.598 ± 0.1938	0.487 ± 0.1082
LYMA (× 103/μL)	2.019 ± 0.7307	1.999 ± 0.4023	2.289 ± 0.8014	2.431 ± 0.6243
MONA (× 103/μL)	0.079 ± 0.0407	0.079 ± 0.0226	0.094 ± 0.0443	0.086 ± 0.0456
EOSA (× 103/μL)	0.055 ± 0.0212	0.052 ± 0.012	0.061 ± 0.0288	0.05 ± 0.025
BASA (× 103/μL)	0.003 ± 0.0048	0.003 ± 0.005	0.001 ± 0.0032	0.004 ± 0.0053
RET% (%)	2.193 ± 0.428	2.252 ± 0.3009	2.147 ± 0.5907	2.17 ± 0.4717
RETA (× 109/μL)	163.65 ± 30.315	169.24 ± 22.426	165.41 ± 42.104	164.41 ± 37.168
APTT (sec)	16.9 ± 1.781	18.1 ± 0.814	17.94 ± 1.861	18.78 ± 0.931
PT (sec)	10.8 ± 0.59	11 ± 0.48	11.4 ± 1.1	11.4 ± 0.61

Data are expressed mean ± S.D.
n, number of animals examined; WBC, white blood cell count; RBC, red blood cell count; HGB, hemoglobin; HCT, hematocrit; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; PLT, platelet; NEU%, neutrophil relative; LYM%, lymphocyte relative; MON%, monocyte relative; EOS%, eosinophil relative; BAS%, basophil relative; NEUA, neutrophil absolute; LYMA, lymphocyte absolute; MONA, monocyte absolute; EOSA, eosinophil absolute; BASA, basophil absolute; RET%, reticulocyte relative; RETA, reticulocyte absolute; APTT, activated partial thromboplastin time; PT, prothrombin time.